Discover
OGEN
Oragenics, Inc.
0.46
300 x 0.45
200 x 0.48
bid
ask
-
0.01
1.51%
250 @ 04:16 PM
0.48 +0.02 (5.22%)
| Ytd | -41.54% | |
| 1y | -67.19% |
0.45
day range
0.48
0.46
52 week range
1.39
| Open | 0.47 | Prev Close | 0.46 | Low | 0.45 | High | 0.48 | Mkt Cap | 2.06M |
| Vol | 28.22K | Avg Vol | 29.43K | EPS | -2.40 | P/E | N/A | Forward P/E | -0.03 |
| Beta | 0.48 | Short Ratio | 0.43 | Inst. Own | 11.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.51 | 200-d Avg | 0.64 | 1yr Est | 90.00 |
| Income Statement | |||
| Operating Expenses | 2.59M | ||
| Research and Development Expense | 1.18M | ||
| Selling, General and Administrative Expense | 1.42M | ||
| Operating Income | -2.59M | ||
| Interest Expense | 414.00 | ||
| Income Tax Expense | -46.38K | ||
| Net Income | -2.53M | ||
| Net Income Common Stock | -2.53M | ||
| Net Income Common Stock (USD) | -2.53M | ||
| Consolidated Income | -2.53M | ||
| Earnings per Basic Share | -0.57 | ||
| Earnings per Basic Share (USD) | -0.57 | ||
| Earnings per Diluted Share | -0.57 | ||
| Earning Before Interest & Taxes (EBIT) | -2.57M | ||
| Earning Before Interest & Taxes (USD) | -2.57M | ||
| Weighted Average Shares | 4.43M | ||
| Weighted Average Shares Diluted | 4.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.86M | ||
| Cash and Equivalents (USD) | 3.86M | ||
| Current Assets | 5.49M | ||
| Total Assets | 5.49M | ||
| Current Liabilities | 1.82M | ||
| Total Liabilities | 1.82M | ||
| Accumulated Retained Earnings (Deficit) | -231.36M | ||
| Shareholders Equity | 3.67M | ||
| Shareholders Equity (USD) | 3.67M | ||
| Trade and Non-Trade Payables | 1.82M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -56.13K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.24M | ||
| Issuance (Repayment) of Debt Securities | -56.13K | ||
| Net Cash Flow from Operations | -2.19M | ||
| Share Based Compensation | 17.58K | ||